S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
BREAKING: Tiny biotech successfully treats blindness (Ad)
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
BREAKING: Tiny biotech successfully treats blindness (Ad)
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
BREAKING: Tiny biotech successfully treats blindness (Ad)
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
BREAKING: Tiny biotech successfully treats blindness (Ad)
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
NYSE:IPI

Intrepid Potash - IPI Stock Forecast, Price & News

$25.98
-0.08 (-0.31%)
(As of 03/23/2023 12:00 AM ET)
Add
Compare
Today's Range
$25.70
$27.08
50-Day Range
$25.98
$33.55
52-Week Range
$25.70
$121.72
Volume
127,582 shs
Average Volume
201,364 shs
Market Capitalization
$336.96 million
P/E Ratio
4.88
Dividend Yield
N/A
Price Target
$34.50

Intrepid Potash MarketRank™ Forecast

Analyst Rating
Hold
1.50 Rating Score
Upside/​Downside
32.8% Upside
$34.50 Price Target
Short Interest
Healthy
4.58% of Float Sold Short
Dividend Strength
N/A
Sustainability
-9.11
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
-90.86%
From $1.97 to $0.18 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.09 out of 5 stars

Basic Materials Sector

104th out of 160 stocks

Mining & Quarrying Of Nonmetallic Minerals, Except Fuels Industry

9th out of 15 stocks


IPI stock logo

About Intrepid Potash (NYSE:IPI) Stock

Intrepid Potash, Inc. is a diversified mineral company, which engages in the delivery of potassium, magnesium, sulfur, salt, and water products essential for customer success in agriculture, animal feed, and the oil and gas industry. It operates through the following segments: Potash, Trio, and Oilfield Solutions. The company was founded in January 2000 and is headquartered in Denver, CO.

Receive IPI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intrepid Potash and its competitors with MarketBeat's FREE daily newsletter.

IPI Stock News Headlines

Q4 2022 Intrepid Potash Inc Earnings Call
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Intrepid Potash Q4 Profit Decreases, misses estimates
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Intrepid Potash Earnings Preview
Intrepid Income Institutional ICMUX
Intrepid Potash: Promising But Not At This Price
Intrepid Potash: Promising But Not At This Price
Intrepid Potash: Why I'm Bullish On This Potash Company
Intrepid Potash Reports Climb In Q3 Income
Intrepid Announces Third Quarter 2022 Results
See More Headlines
Receive IPI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intrepid Potash and its competitors with MarketBeat's FREE daily newsletter.

IPI Company Calendar

Last Earnings
3/06/2023
Today
3/23/2023
Next Earnings (Estimated)
5/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Mining & quarrying of nonmetallic minerals, except fuels
Sub-Industry
Fertilizers & Agricultural Chemicals
CUSIP
46121Y10
Employees
440
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$34.50
High Stock Price Forecast
$40.00
Low Stock Price Forecast
$29.00
Forecasted Upside/Downside
+32.8%
Consensus Rating
Hold
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

Net Income
$72.22 million
Pretax Margin
28.59%

Debt

Sales & Book Value

Annual Sales
$337.57 million
Cash Flow
$8.52 per share
Book Value
$53.01 per share

Miscellaneous

Free Float
10,612,000
Market Cap
$336.96 million
Optionable
Optionable
Beta
2.01

Key Executives

  • Robert P. Jornayvaz
    Executive Chairman & Chief Executive Officer
  • Matthew D. Preston
    Chief Financial & Accounting Officer
  • Alex J. Wagner
    Vice President-Business Development
  • Zachry Adams
    Vice President-Sales & Marketing
  • Scott E. Earnest
    Vice President-Taxation













IPI Stock - Frequently Asked Questions

Should I buy or sell Intrepid Potash stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Intrepid Potash in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" IPI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IPI, but not buy additional shares or sell existing shares.
View IPI analyst ratings
or view top-rated stocks.

What is Intrepid Potash's stock price forecast for 2023?

2 Wall Street analysts have issued 1 year target prices for Intrepid Potash's stock. Their IPI share price forecasts range from $29.00 to $40.00. On average, they expect the company's stock price to reach $34.50 in the next year. This suggests a possible upside of 32.8% from the stock's current price.
View analysts price targets for IPI
or view top-rated stocks among Wall Street analysts.

How have IPI shares performed in 2023?

Intrepid Potash's stock was trading at $28.87 on January 1st, 2023. Since then, IPI stock has decreased by 10.0% and is now trading at $25.98.
View the best growth stocks for 2023 here
.

Are investors shorting Intrepid Potash?

Intrepid Potash saw a decrease in short interest during the month of February. As of February 28th, there was short interest totaling 413,400 shares, a decrease of 6.5% from the February 13th total of 442,200 shares. Based on an average trading volume of 221,100 shares, the short-interest ratio is presently 1.9 days. Approximately 4.6% of the company's stock are short sold.
View Intrepid Potash's Short Interest
.

When is Intrepid Potash's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 1st 2023.
View our IPI earnings forecast
.

How were Intrepid Potash's earnings last quarter?

Intrepid Potash, Inc. (NYSE:IPI) released its quarterly earnings data on Monday, March, 6th. The basic materials company reported $0.83 earnings per share for the quarter, missing analysts' consensus estimates of $0.94 by $0.11. The basic materials company had revenue of $66.68 million for the quarter, compared to analyst estimates of $63.94 million. Intrepid Potash had a net margin of 21.39% and a trailing twelve-month return on equity of 11.27%. During the same period in the prior year, the firm posted $0.60 earnings per share.

What ETFs hold Intrepid Potash's stock?
How will Intrepid Potash's stock buyback program work?

Intrepid Potash announced that its Board of Directors has initiated a stock buyback program on Monday, March 7th 2022, which authorizes the company to buyback $35,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to repurchase up to 3.9% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's management believes its stock is undervalued.

What is Robert P. Jornayvaz III's approval rating as Intrepid Potash's CEO?

6 employees have rated Intrepid Potash Chief Executive Officer Robert P. Jornayvaz III on Glassdoor.com. Robert P. Jornayvaz III has an approval rating of 78% among the company's employees.

What other stocks do shareholders of Intrepid Potash own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Intrepid Potash investors own include Navios Maritime (NM), General Electric (GE), Cleveland-Cliffs (CLF), Amedica (AMDA), Freeport-McMoRan (FCX), Sangamo Therapeutics (SGMO), Enphase Energy (ENPH), Energy Transfer (ET) and Gilead Sciences (GILD).

What is Intrepid Potash's stock symbol?

Intrepid Potash trades on the New York Stock Exchange (NYSE) under the ticker symbol "IPI."

Who are Intrepid Potash's major shareholders?

Intrepid Potash's stock is owned by a number of retail and institutional investors. Top institutional investors include Dimensional Fund Advisors LP (5.73%), Morgan Stanley (1.60%), Investment Management of Virginia LLC (1.54%), Geode Capital Management LLC (1.41%), AQR Capital Management LLC (1.14%) and Simplex Trading LLC (0.00%). Insiders that own company stock include Clearway Capital Management Ll, Matthew D Preston and Robert E Baldridge.
View institutional ownership trends
.

How do I buy shares of Intrepid Potash?

Shares of IPI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Intrepid Potash's stock price today?

One share of IPI stock can currently be purchased for approximately $25.98.

How much money does Intrepid Potash make?

Intrepid Potash (NYSE:IPI) has a market capitalization of $336.96 million and generates $337.57 million in revenue each year. The basic materials company earns $72.22 million in net income (profit) each year or $5.32 on an earnings per share basis.

How many employees does Intrepid Potash have?

The company employs 440 workers across the globe.

How can I contact Intrepid Potash?

Intrepid Potash's mailing address is 1001 17thStreet Suite1050, DENVER CO, 80202. The official website for the company is www.intrepidpotash.com. The basic materials company can be reached via phone at (303) 296-3006, via email at ir@intrepidpotash.com, or via fax at 303-298-7502.

This page (NYSE:IPI) was last updated on 3/24/2023 by MarketBeat.com Staff